SZShuaizhen Zhou

Shuaizhen Zhou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shuaizhen Zhou has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Lymph-Targeted Resveratrol-NLCs Improve Oral Bioavailability: Validation via Rat Mesenteric Lymph Collection System and In Vivo Safety

    by Xiaorui Zhang, Wenli Shi, Xinlin Yang, Yuchen Lin, Bo Yang, Hui Deng, Daojin Yu, Shuaizhen Zhou

    Resveratrol (RES) is a natural polyphenolic compound characterized by poor aqueous solubility and significant first-pass metabolism, resulting in extremely low oral bioavailability. Although resveratrol-loaded nanostructured lipid carriers (RES-NLCs) have shown potential in enhancing oral absorption, direct experimental evidence for their intestinal lymphatic transport mechanism remains limited, and existing explanations is largely based on indirect inference. RES-NLCs were prepared, and their pharmacokinetics and lymphatic transport characteristics were evaluated using a laboratory-established mesenteric lymph duct–jugular vein assisted reflux model in rats. Simultaneously, a 28-day repeated-dose toxicity study was conducted in ICR mice. Pharmacokinetic results showed that compared with RES-Sol, RES-NLCs increased Cmax by approximately 2.3-fold, improved relative bioavailability by 7-fold, and achieved an absolute bioavailability of 176%. The lymphatic transport model confirmed that RES-NLCs are absorbed via the intestinal lymphatic pathway. In the 28-day repeated-dose toxicity study, no mortality or obvious clinical symptoms were observed at a dose of 10 mg/kg. The RES-NLCs group exhibited increased liver coefficient and decreased spleen coefficient. Hematological analysis showed a mild increase in red blood cell count, along with decreases in mean corpuscular volume and red blood cell distribution width coefficient of variation. Serum biochemistry revealed significant elevations in aspartate aminotransferase and alanine aminotransferase (p = 9 × 10−5 and p = 4.02 × 10−7, respectively). However, no significant differences were observed in the organ coefficients of the heart, lungs, kidneys, or brain. Body composition and magnetic resonance imaging showed no abnormalities, and histopathological examination of major organs including the liver, stomach, and intestines revealed no structural damage. These findings provide direct evidence that RES-NLCs enhance the oral bioavailability by promoting intestinal lymphatic uptake, suggesting that this system may serve as an effective delivery platform for poorly soluble hydrophobic drugs.

  • Open Access

    Maternal Polystyrene Nanoplastic Exposure Impairs Cardiac Development in Mouse Offspring and Identifies Lactation as a Sensitive Window in Males

    by Xiaorui Zhang, Yingguang Li, Xiaotao Zhang, Wenli Shi, Hui Deng, Lingxian Yi, Shuaizhen Zhou, Daojin Yu

    Maternal exposure to nanoplastics is a growing concern, but its effects on offspring cardiac development and the relative importance of prenatal and lactational exposure remain unclear. Pregnant C57BL/6J mice were orally exposed to 50 nm polystyrene nanoplastics at 3, 15, or 75 μg/g body weight from gestational day 1 to postnatal day 21. A cross-fostering design was used to distinguish gestational exposure from lactational exposure. Maternal polystyrene nanoplastic exposure caused dose-dependent cardiac dysfunction in offspring, including reduced ejection fraction and fractional shortening, increased myocardial injury markers, cardiomyocyte hypertrophy, and fibrosis. Cross-fostering showed that lactationally exposed offspring exhibited more severe cardiac abnormalities than offspring exposed only during gestation, indicating that the nursing period may represent a more vulnerable window. In male offspring, polystyrene nanoplastic exposure was also associated with gut microbiota dysbiosis and cardiac transcriptomic changes. Enrichment analysis identified downregulation of genes related to AMP-activated protein kinase signalling, and integrated microbiome–transcriptome analysis suggested associations between altered gut taxa and cardiac differentially expressed genes. These findings indicate that maternal polystyrene nanoplastic exposure induces offspring cardiac developmental toxicity, with stronger effects during lactation, and suggest the involvement of gut microbial and cardiac molecular remodelling.

  • Enhancing lipid production in plant cells through automated high-throughput genome engineering and phenotyping

    by Jia Dong, Seth W Croslow, Stephan T Lane, Daniel C Castro, Jantana Blanford, Shuaizhen Zhou, Kiyoul Park, Steven Burgess, Mike Root, Edgar B Cahoon, et al.

    Plant bioengineering is a time-consuming and labor-intensive process with no guarantee of achieving desired traits. Here, we present a fast, automated, scalable, high-throughput pipeline for plant bioengineering (FAST-PB) in maize (Zea mays) and Nicotiana benthamiana. FAST-PB enables genome editing and product characterization by integrating automated biofoundry engineering of callus and protoplast cells with single-cell matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS). We first demonstrated that FAST-PB could streamline Golden Gate cloning, with the capacity to construct 96 vectors in parallel. Using FAST-PB in protoplasts, we found that PEG2050 increased transfection efficiency by over 45%. For proof-of-concept, we established a reporter-gene-free method for CRISPR editing and phenotyping via mutation of high chlorophyll fluorescence 136. We show that diverse lipids were enhanced up to 6-fold using CRISPR activation of lipid controlling genes. In callus cells, an automated transformation platform was employed to regenerate plants with enhanced lipid traits through introducing multigene cassettes. Lastly, FAST-PB enabled high-throughput single-cell lipid profiling by integrating MALDI-MS with the biofoundry, protoplast, and callus cells, differentiating engineered and unengineered cells using single-cell lipidomics. These innovations massively increase the throughput of synthetic biology, genome editing, and metabolic engineering and change what is possible using single-cell metabolomics in plants.


  • Open Access

    Expanding the Chemical Diversity of Stemona parviflora: Isolation and Characterization of New Parvistemoline-Type Alkaloids

    by Shuaizhen Zhou, Ruolin Geng, Changqiang Ke, Fan Ge, Ying Chen, Chunping Tang, Yang Ye

    A comprehensive phytochemical investigation of the whole plant of Stemona parviflora led to the isolation of 13 alkaloidal constituents, including five new alkaloids, parvistemonines B–F (1–5). The structures of these compounds were elucidated through extensive analyses of 1D and 2D NMR spectra, DFT NMR calculation, and comparisons with data in the literature. Notably, compounds 1–4 represent new examples of the rare parvistemoline-type alkaloids, with compound 4 showcasing a unique rearranged skeleton. Additionally, parvistemonine F (5) was identified as a distinct alkaloid skeleton characterized by a n-butyl side chain. These findings significantly expand our understanding of the chemical diversity of parvistemoline-type alkaloids and provide clues for elucidating the biosynthetic pathways of these structurally unique parvistemoline alkaloids.

  • Open Access

    Expanding the Chemical Diversity of Stemona parviflora: Isolation and Characterization of New Parvistemoline-Type Alkaloids

    by Shuaizhen Zhou, Ruolin Geng, Chang-Qiang Ke, Fan Ge, Ying Chen, Chunping Tang, Yang Ye

    A comprehensive phytochemical investigation of the whole plant of Stemona parviflora led to the isolation of 13 alkaloidal constituents, including five new alkaloids: 13α-hydroxyparvistemonine (1), 12α-methoxyparvistemonine (2), parvistemonine-N-oxide (3), parvistemoninine (4), and parvistemofoline (5). The structures of these compounds were elucidated through extensive analyses of 1D and 2D NMR spectra, DFT NMR calculation, and comparisons with data in literature. Notably, compounds 1-4 represent new examples of the rare parvistemoline-type alkaloids, with compound 4 showcasing a unique rearranged skeleton. Additionally, parvistemofoline (5) was identified as a distinct alkaloid skeleton characterized by a n-butyl side chain. These findings significantly expand our understanding of the chemical diversity of parvistemoline-type alkaloids, and provide clues for elucidating the biosynthetic pathways of these structurally unique parvistemoline alkaloids.

  • Open Access

    Enhancing 2‐Pyrone Synthase Efficiency by High‐Throughput Mass‐Spectrometric Quantification and In Vitro/In Vivo Catalytic Performance Correlation

    by Yu Zhou, Shuaizhen Zhou, Scott Lyons, Haoran Sun, Jonathan V. Sweedler, Yi Lu

    Engineering efficient biocatalysts is essential for metabolic engineering to produce valuable bioproducts from renewable resources. However, due to the complexity of cellular metabolic networks, it is challenging to translate success in vitro into high performance in cells. To meet such a challenge, an accurate and efficient quantification method is necessary to screen a large set of mutants from complex cell culture and a careful correlation between the catalysis parameters in vitro and performance in cells is required. In this study, we employed a mass‐spectrometry based high‐throughput quantitative method to screen new mutants of 2‐pyrone synthase (2PS) for triacetic acid lactone (TAL) biosynthesis through directed evolution in E. coli. From the process, we discovered two mutants with the highest improvement (46 fold) in titer and the fastest kcat (44 fold) over the wild type 2PS, respectively, among those reported in the literature. A careful examination of the correlation between intracellular substrate concentration, Michaelis‐Menten parameters and TAL titer for these two mutants reveals that a fast reaction rate under limiting intracellular substrate concentrations is important for in‐cell biocatalysis. Such properties can be tuned by protein engineering and synthetic biology to adopt these engineered proteins for the maximum activities in different intracellular environments.


  • Mass Spectrometry-Based High-Throughput Quantification of Bioproducts in Liquid Culture

    by Shuaizhen Zhou, Zia Fatma, Pu Xue, Shekhar Mishra, Mingfeng Cao, Huimin Zhao, Jonathan V. Sweedler

    To meet the ever-increasing need for high-throughput screening in metabolic engineering, information-rich, fast screening methods are needed. Mass spectrometry (MS) provides an efficient and general approach for metabolite screening and offers the capability of characterizing a broad range of analytes in a label-free manner, but often requires a range of sample clean-up and extraction steps. Liquid extraction surface analysis (LESA) coupled MS is an image-guided MS surface analysis approach that directly samples and introduces metabolites from a surface to MS. Here, we combined the advantages of LESA-MS and an acoustic liquid handler with stable isotope-labeled internal standards. This approach provides absolute quantitation of target chemicals from liquid culture-dried droplets and enables high-throughput quantitative screening for microbial metabolites. In this study, LESA-MS was successfully applied to quantify several different metabolites (itaconic acid, triacetic acid lactone, and palmitic acid) from different yeast strains in different mediums, demonstrating its versatility, accuracy, and efficiency across a range of microbial engineering applications.